-
Man's Award in Roundup Cancer Case Slashed by Judge
drugs
July 18, 2019
A man who was awarded $80.27 million in a lawsuit alleging Monsanto's Roundup weedkiller caused his cancer had that amount cut by $55 million by a judge.
-
Depression at Time of Diagnosis May Worsen Survival in Blood Cancers
drugs
July 17, 2019
Depression at Time of Diagnosis May Worsen Survival in Blood Cancers.
-
Hurricanes Can Hurt Survival Odds Among Those With Cancer
drugs
July 17, 2019
When a hurricane strikes, as tropical storm Barry did this weekend in Louisiana, most people worry about the immediate health dangers such a storm poses.
-
Colonoscopy Rates Increased in Those Aged 45 to 54 Years
drugs
July 17, 2019
From 2000 to 2015, colonoscopy rates increased among those aged 45 to 54 years, while colorectal cancer incidence increased among those aged 40 to 54 years...
-
Boehringer Ingelheim Acquires AMAL Therapeutics
americanpharmaceuticalreview
July 16, 2019
Boehringer Ingelheim announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and ...
-
Many Perceive Lack of Choice in Receipt of RAI for Thyroid Cancer
drugs
July 16, 2019
Many Perceive Lack of Choice in Receipt of RAI for Thyroid Cancer.
-
Newer Lung Cancer Screening Saves More Lives
drugs
July 16, 2019
A newer form of lung cancer screening may mean fewer deaths from the disease, a new study contends.
-
Serious Misdiagnosis-Related Harms Mostly Due to 'Big Three'
drugs
July 15, 2019
Vascular events, infections, and cancers account for about three-quarters of serious misdiagnosis-related harms, according to a study published online in Diagnosis.
-
State-Level Variation Noted in Economic Burden of Cancer
drugs
July 15, 2019
There is considerable state-level variation in the economic burden of cancer, according to a study published online in JAMA Oncology.
-
Risk for Cancer Higher in Those With Congenital Heart Disease
drugs
July 11, 2019
Risk for Cancer Higher in Those With Congenital Heart Disease.